Home | C2iVax

C2iVax Advances Global Health with Best-in-Class, Innovative Vaccines for Influenza and Other Respiratory Diseases

Our Methodology

Our Mission

We are dedicated to advance the development of novel, needle-free, broadly protective live-attenuated vaccines to combat respiratory diseases. Our mission is to control disease outbreak and alleviate public health burden with effective and affordable vaccines.

C2iVax is a spin-off company of the InnoHK Centre for Immunology & Infection (InnoHK C2i), a major initiative fruit of a long-standing partnership of more than 20 years between the LKS Faculty of Medicine of the University of Hong Kong (HKUMed) and the Institut Pasteur.